National and regional characteristics of methadone prescribing in England and Wales: local analyses of data from the 1995 national survey of community pharmacies

References

• Advisory Council on the Misuse of Drugs. AIDS and drugs misuse; Update report. Her Majesty's Stationery Office, London 1993
   Google Scholar
• Ball J C, Ross A. The effectiveness of methadone maintenance treatment: patients, programmes, services, and outcome. Springer-Verlag, New York 1991
   Google Scholar
• Beaumont B. Care of drug use in general practice: a harm minimisation approach. Radcliffe Medical Press, Oxford 1997
   Google Scholar
• Bell G, Cohen J, Cremona A. How willing are general practitioners to manage narcotic misuse?. Health Trends 1990; 22: 56–57
   PubMedGoogle Scholar
• Cairns A, Roberts I S D, Benbow E W. Characteristics of fatal methadone overdose in Manchester, 1985–1994. British Medical Journal 1996; 313: 264–265
   PubMed Web of Science ®Google Scholar
• Caplehorn J, Ross M. Methadone maintenance and the likelihood of risky needle sharing. International Journal of the Addictions 1995; 30: 685–698
   PubMed Web of Science ®Google Scholar
• Caplehorn J, Bell J, Kleinbaum D G, Gebski V J. Methadone dose and heroin use during maintenance treatment. Addiction 1993; 88: 119–124
   PubMed Web of Science ®Google Scholar
• Deehan A, Taylor C, Strang J. The general practitioner, the drug misuser and the alcohol misuser: major differences in general practitioner activity, therapeutic commitment, and ‘shared care’ proposals. British Journal of General Practice 1997; 47: 705–709
   PubMed Web of Science ®Google Scholar
• Department of Health, Scottish Home and Health Department and Welsh Office. Drug misuse and dependence: guidelines on clinical management. HMSO, London 1991
   Google Scholar
• Department of Health. The Task Force to review services for drug misusers - report of an independent review of drug treatment services in England. HMSO, London 1996
   Google Scholar
• Dole V P, Nyswander M. Medical treatment for diacetyl morphine (heroin) addiction. Journal of the American Medical Association 1965; 193: 80–84
   Web of Science ®Google Scholar
• Dole V P, Nyswander W. Heroin addiction - a metabolic disease. Archives of internal medicine 1967; 120: 19–24
   PubMed Web of Science ®Google Scholar
• Farrell M, Ward J, Des Jarlais D C, Gossop M, et al. Methadone maintenance programmes: review of new data with special reference to impact on HIV transmission. British Medical Journal 1994; 309: 997–1001
   PubMed Web of Science ®Google Scholar
• Farrell M, Sell L, Neeleman J, et al. Methadone provision in the UK. The International Journal of Drug Policy 1996; 7: 239–244
   Google Scholar
• Glanz A, Taylor C. Findings of a national survey on the role of general practitioners in the treatment of opiate misuse: extent of contact. British Medical Journal 1986; 293: 427–430
   PubMed Web of Science ®Google Scholar
• Glanz A. The fall and rise of the general practitioner. Heroin addiction and drug policy: the British system, J S Strang, M Gossop. Oxford University Press, Oxford 1994; 151–166
   Google Scholar
• Gossop M, Marsden J, Stewart D, Edwards C, Lehmann P, Wilson A, Segar G. The National Treatment Outcome Research Study in the United Kingdom: six month follow-up outcomes. Psychology of Addictive Behaviours 1997; 11: 324–337
   Web of Science ®Google Scholar
• Gruer L, Wilson P, Scott R, et al. General practitioner centred scheme for treatment of opiate dependent drug injectors in Glasgow. British Medical Journal 1997; 314: 1730–1735
   PubMed Web of Science ®Google Scholar
• Home Office. Statistics of drug addicts notified to the Home Office, United Kingdom, 1987–95. HMSO, London 1988-96, Home Office Statistical Bulletin No. 10/94
   Google Scholar
• McGlothlin W H, Anglin M D. Long term follow-up of clients of high and low dose methadone programmes. Archives of General Psychiatry 1981; 38: 1055–1063
   PubMed Web of Science ®Google Scholar
• Sheridan J, Strang J, Barber N, Glanz A. Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales. British Medical Journal 1996; 313: 272–274
   PubMed Web of Science ®Google Scholar
• Strang J, Sheridan J, Barber N. Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national survey of community pharmacies in England and Wales. British Medical Journal 1996; 313: 270–272
   PubMed Web of Science ®Google Scholar
• Strang J, Finch E, Hankinson L, Farrell M, Taylor C, Gossop M. Methadone treatment for opiate addiction: benefits in the first month. Addiction Research 1997; 5: 71–76
   Web of Science ®Google Scholar
• Strang J, Sheridan J. Heroin-prescribing in the ‘British system’ of the mid 1990's: data from the 1995 national survey of community pharmacies in England and Wales. Drug and Alcohol Review 1997a; 16: 7–16
   PubMed Web of Science ®Google Scholar
• Strang J, Sheridan J. Prescribing amphetamines to drug misusers: data from the 1995 national survey of community pharmacies in England and Wales. Addiction 1997b; 92: 833–838
   PubMedGoogle Scholar
• Tantam D, Donmall M, Webster A, Strang J. Do general practitioners and general psychiatrists be expected to look after drug misusers? Evaluation of a non-specialist treatment policy. British Journal of General Practice 1993; 43: 470–474
   PubMed Web of Science ®Google Scholar
• UK Government. Tackling drugs together: a strategy for England, 1995–1998. HMSO, London 1995
   Google Scholar
• UK Government. Tackling drugs to build a better Britain. HMSO, London 1998
   Google Scholar
• Ward J, Mattick R, Hall W. Key issues in methadone maintenance treatment. University of New South Wales Press, SydneyAustralia 1992
   Google Scholar
• Wilson P, Watson R, Ralston G E. Methadone maintenance in general practice: patients, workloads and outcomes. British Medical Journal 1994; 309: 641–644
   PubMed Web of Science ®Google Scholar